About this case:
Regulation (EEC) No 1768/92 – Medicinal products – Supplementary protection certificate – Certificate of negative duration
Request for an Advisory Opinion from the EFTA Court by the Supreme Court of Iceland (Hæstiréttur Íslands), received on 15 June 2017 in the case of Merck Sharp & Dohme Corp. v the Icelandic Patent Office (Einkaleyfastofan)
22/06/2017
Deadline for written observations from Governments and relevant institutions (cf. Article 20 of the Statute): Tuesday, 22 August 2017
15/08/2017
Written observations received from the Icelandic Patent Office
21/08/2017
Written observations received from the Government of Norway
22/08/2017
Written observations received from the European Commission
22/08/2017
Written observations received from Merck Sharp & Dohme Corp.
22/08/2017
Written observations received from the EFTA Surveillance Authority
25/08/2017
Service of the written observations